Document |
Document Title |
WO/2022/226495A1 |
The present invention is directed to a method for treating spinal cord injury. The method comprises administering to a subject in need thereof 3-methanesulfonylpropionitrile (dapansutrile), or a pharmaceutically acceptable solvate thereo...
|
WO/2022/217364A1 |
A new class of antibiotics, namely, mercaptoacetophenone aminohydrazones, their analogues, their method of preparation, their salts, and their use in cases of bacterial infections, either alone or with other compounds.
|
WO/2022/202345A1 |
The present invention provides: an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which decomposes by the action of an acid to increase in polarity and (B) a compound which generates an acid upon ir...
|
WO/2022/202994A1 |
The present description discloses: a dried PRENCSO composition having improved storage stability; and a lachrymatory factor generation kit in which the dried PRENCSO composition is used. The dried PRENCSO composition according to the p...
|
WO/2022/166848A1 |
Provided is a method for synthesizing (1R,2R)-AMPP and derivatives thereof by using an enzyme cascade reaction, comprising the following steps: step 1, using a benzaldehyde derivative as a substrate and an E. coli transketolase mutant as...
|
WO/2022/166837A1 |
Disclosed are an aryl sulfide, a synthesis method therefor, and an application thereof. The aryl sulfide is a compound of the structure represented by formula I or an agriculturally acceptable salt thereof. The aryl sulfide and the agric...
|
WO/2022/165105A1 |
Oxidized disulfide oil (ODSO) compounds or ODSO compounds and disulfide oil (DSO) compounds are added to a steam cracker feed. During the thermal cracking, the ODSO or ODSO and DSO components in the steam cracker mixture minimize coke fo...
|
WO/2022/149462A1 |
A light-absorbing material according to one embodiment of the present disclosure includes a compound represented by formula (1) as a main component. In formula (1): R1 to R30 are independent of each other and include at least one element...
|
WO/2022/125620A1 |
There is currently a high demand for new therapeutic antibiotics with new mechanisms of action. Disclosed are two small molecules, tryglysin A and B, with novel chemical structures and potent antibiotic activity against a narrow spectrum...
|
WO/2022/115953A1 |
The present disclosure describes compositions including a eutectic matrix that includes methylsulfonylmethane and a sugar alcohol and particles of a nutraceutical in the eutectic matrix. In some embodiments, the sugar alcohol:methylsulfo...
|
WO/2022/110958A1 |
The present disclosure relates to an HDAC inhibitor containing a RAS/RAF protein interfering group, and a preparation method therefor. Known 2,4,6-trimethoxyphenyl-4-methoxy-3-aminobenzyl sulfone, which targets RAS/RAF and is a capping g...
|
WO/2022/115742A1 |
The disclosure is directed to, in part, compounds, or pharmaceutically acceptable salts or solvates thereof, for modulating the activity of aldehyde dehydrogenase such as ALDH2 and/or methods for treating and/or preventing an alcohol rel...
|
WO/2022/096682A1 |
The invention relates to a method of preparing arylvinylsulphones. The method comprises forming o a first reaction mixture comprising a catalyst complex of Cu(I)halide and a ligand, wherein the ligand is selected from mono-, bi- or polyd...
|
WO/2022/084990A1 |
There are provided novel Ring-Closure Intermediates of formulae 1 and 1', as defined herein, including salts and N-Oxides of the 3-pyridine substituted examples thereof, and novel precursor compounds 5 and b etc., as defined herein, all ...
|
WO/2022/083082A1 |
The present invention provides a method for preparing bicalutamide intermediate 2, comprising the following steps: dissolving N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methacrylamide in a lower fatty acid ester solvent, successively adding...
|
WO/2022/058733A1 |
The present invention relates to compounds for stabilising the native tetrameric form of transthyretin and protecting it from proteolytic cleavage; compounds for use in the prevention and treatment of transthyretin amyloidosis; and agent...
|
WO/2022/035804A1 |
The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof and pharmaceutical composition comprising the compound of formula (I). The present composition also relates to methods treating a d...
|
WO/2022/024856A1 |
The present invention provides: an active-ray-sensitive or radiation-sensitive resin composition comprising a compound represented by general formula (I); an active-ray-sensitive or radiation-sensitive film formed by using the active-ray...
|
WO/2022/012483A1 |
The present invention relates to the field of agricultural acaricides, and in particular to a substituted phenyl sulfide compound and an application thereof. The substituted phenyl sulfide compound is as represented by general formula I....
|
WO/2022/012482A1 |
The present invention belongs to the field of organic synthesis, and particularly relates to a method for preparing a mesotrione herbicide. 4-methanesulfonyl-2-nitrobenzoic acid is used as a raw material, and is subjected to a chloroform...
|
WO/2022/015181A1 |
The invention relates to a method and intermediate compounds for the preparation of menaquinone MK-7. The method for the preparation of menaquinone MK-7 is characterized in that, it comprises coupling of a compound of formula (11) with a...
|
WO/2021/255737A1 |
The present disclosure pertains to amino cyclohexanone compounds, pharmaceutical compositions containing same and methods of treating depression, pain, inflammation, and other clinical indications.
|
WO/2021/252640A1 |
The present disclosure relates to compounds of formulas (A) and (I), pharmaceutically acceptable salts thereof, and solvates of any of the foregoing, pharmaceutical compositions comprising the same, methods of preparing the same, interme...
|
WO/2021/237371A1 |
The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected ...
|
WO/2021/228215A1 |
The present invention relates to a compound of formula (I), a stereoisomer, a tautomer, a stable isotope variant, a pharmaceutically acceptable salt or a solvate thereof, a pharmaceutical composition comprising same, a method for treatin...
|
WO/2021/223301A1 |
Provided is a preparation method for water-soluble Florfenicol amino acid ester salt, the method comprising the steps of: using Florfenicol and N-Cbz-amino acid as starting raw materials, and subjecting same to acyl chlorination, esterif...
|
WO/2021/219556A1 |
A dye mixture comprising at least one dye of formula (formula) and at least one dye of formula (formula), wherein R1 is hydrogen or C1-C4alkyl, R2 is hydrogen or C1-C4alkyl, C1-C4alkoxy or sulfo, Q1 is a fibre-reactive radical of formula...
|
WO/2021/220648A1 |
Provided are a method for forming a resist pattern and a radiation-sensitive resin composition which, even when a next-generation exposure technology is applied thereto, have excellent performances concerning sensitivity during exposure ...
|
WO/2021/215365A1 |
Provided are: a methane-production inhibitor which can inhibit methane production over a long period; and a method for inhibiting methane production using the inhibitor. This methane-production inhibitor composition is characterized by c...
|
WO/2021/217041A1 |
Disclosed are N-substituted α-amino and α-hydroxy carboxamides, pharmaceutical compositions comprising them, and methods of using them.
|
WO/2021/217040A1 |
Disclosed are carbamate and urea derivatives, pharmaceutical compositions comprising them, and methods of using them.
|
WO/2021/200179A1 |
The present invention provides an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which increases in polarity by the action of an acid and (B) a compound which generates an acid upon irradiation with...
|
WO/2021/195765A1 |
A method for treating patients with COVID-19 and/or other respiratory conditions include administering a dosage of 75-100 milligrams of dapsone twice daily. A variety of dapsone formulation and delivery devices are disclosed, including a...
|
WO/2021/188769A1 |
Compounds that inhibit HIF-2a, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse arr...
|
WO/2021/187215A1 |
In the present invention, a diphenylsulfone compound containing 4,4'-dihydroxydiphenylsulfone is produced at a good yield in a short time at a relatively low temperature. A diphenylsulfone compound represented by formula (2) is produced ...
|
WO/2021/184649A1 |
The present invention relates to the technical field of chemosynthesis, and provides a method for preparing a florfenicol intermediate. The method comprises: under catalysis of a chiral catalyst, enabling p-methylthiobenzaldehyde to reac...
|
WO/2021/179049A1 |
The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.
|
WO/2021/180655A1 |
The present invention provides novel hydroquinone derivatives of formula (I), processes of preparation, as well as pharmaceutical compositions and methods of treating and/or preventing e.g. autoimmune, immunological, rheumatology, vascul...
|
WO/2021/181029A1 |
The present invention relates to a chemoenzymatic process for coproducing a disulfide and a sulfoxide or a sulfone from a composition M comprising: 1) a sulfide, 2) optionally an oxidizing agent, 3) an organic compound bearing at least o...
|
WO/2021/174748A1 |
The present invention relates to a method for preparing a visible light catalyzed dichlorine addition product of an aliphatic olefin, comprising the following steps: using an aliphatic olefin as a substrate, using copper chloride having ...
|
WO/2021/177334A1 |
The present invention addresses the problem of providing novel fluoroalkane derivatives that are of a low-molecular-weight type having no hydrogen-bonding functional groups in the molecule, are capable of gelling a wide range of organic ...
|
WO/2021/172111A1 |
The present invention provides a pattern formation method having (i) a step for forming an actinic ray-sensitive or radiation-sensitive film 700 nm or more thick by a specific actinic ray-sensitive or radiation-sensitive resin compositio...
|
WO/2021/165195A1 |
The present invention relates to novel heteroaryl-triazole compounds of the general formula (I), in which the structural elements X, Y, R1, R2, R3a, R3b, R4 and R5 have the meaning given in the description, to formulations and compositio...
|
WO/2021/167046A1 |
Provided are a novel crystal form of 4,4'-bis(2,3-dibromopropoxy)-3,3',5,5'-tetrabromodiphenyl sulfone having excellent thermal stability and a high melting point and a method for producing the crystal form. A crystal form (II-form cry...
|
WO/2021/154143A1 |
The invention concerns a method for treatment of a stream of mixed compounds (4a) obtained from a process (3) comprising decomposition and/or conversion of a wood or pulp material, the method comprising: feeding the stream (4a-4e) throug...
|
WO/2021/153720A1 |
The present invention provides: a 3-alkoxy benzoic acid amide derivative having an excellent pest control effect, or a salt thereof; and a pest control agent and a production intermediate which contain the same as an active ingredient.ã€...
|
WO/2021/136742A1 |
The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein R1, R2, R3 and R4 are as defined herein. The invention further relates to herbicidal compositions which comprise a c...
|
WO/2021/136326A1 |
The present application relates to the technical field of medicine, and relates to an aryl amide compound and an application thereof in medicine. Provided are an aryl amide compound having RORγt activity and a preparation method therefo...
|
WO/2021/123116A1 |
The present invention relates to a compound represented by the following formula (I): A[B-(C)v]w, wherein A is a photoprotective moiety, B is a linker, C is a functional group, v is an integer from 1 to 2000, and w is an integer from 1 t...
|
WO/2021/126746A1 |
Corrosion inhibitor compositions and methods for inhibiting corrosion on a metal surface exposed to a hydrocarbon fluid are provided. The corrosion inhibitor composition can comprise 2-aminoterephthalic acid, dimethyl sulfoxide and heavy...
|